Abdominal Aortic Aneurysm clinical trials at UCSF

5 in progress, 3 open to eligible people

An abdominal aortic aneurysm is a bulge in the main artery that carries blood from the heart to the lower body. UCSF is studying how safe and effective a new method is for treating these aneurysms using a special tube inside the artery. Another study compares two types of devices used in this treatment.

Showing trials for

  • Endovascular Exclusion of Thoracoabdominal And/or Paravisceral Abdominal Aortic Aneurysm

    open to eligible people ages 18 years and up

    This is a study to assess the safety and effectiveness of endovascular treatment of thoracoabdominal (TAAA) and paravisceral abdominal (PVAAA) aortic aneurysms. The investigational operation involves placing a stent-graft over the aortic aneurysm.

    San Francisco, California and other locations

  • Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial

    open to eligible people ages 20 years and up

    The purpose of this trial is to generate clinical evidence related to key performance outcomes of Endurant II/IIs Stent Graft Systems verses Gore Excluder / Excluder Conformable AAA Endoprosthesis in subjects with Abdominal Aortic Aneurysms. Subjects are randomized and imaging collected at all follow-up time points to assess the primary endpoint.

    San Francisco, California and other locations

  • Follow-up After Endovascular Repair of Abdominal Aortic Aneurysm

    open to eligible people ages 18 years and up

    To collect and analyze clinical follow-up data which can be used to assess the safety, efficacy, and durability of endovascular AAA repair with Zenith and Chuter-Gianturco stent-grafts.

    San Francisco, California and other locations

  • Nectero EAST System Clinical Study

    Sorry, currently not accepting new patients, but might later

    The purpose of this randomized clinical trial is to treat patients with small to mid-sized abdominal aortic aneurysms (AAA), maximum diameter of 3.5 cm to 5.0 cm, using a locally delivered, single-dose endovascular treatment. The main question the study aims to answer is to demonstrate efficacy of the product for stabilization of these small to mid-sized AAA.The study will compare the treatment group to the typical standard of care for these patients, surveillance. All subjects will be followed at designated intervals at 30/60 days, 6, 12, 18 and 24 months with continued follow-up annually for up to 5 years.

    San Francisco, California and other locations

  • Zenith® Fenestrated Abdominal Aortic Aneurysm (AAA) Endovascular Graft Continued Access Study

    Sorry, not accepting new patients

    The Zenith®Fenestrated AAA Endovascular Graft Clinical Study is a clinical investigation approved by the US FDA to study the safety and effectiveness of the Zenith® Fenestrated AAA Endovascular Graft in the treatment of abdominal aortic and aorto-iliac aneurysms.

    San Francisco, California and other locations

Our lead scientists for Abdominal Aortic Aneurysm research studies include .

Last updated: